Nikolaus Osterrieder

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Merial Limited, Cornell University, Novartis Ag. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolaus Osterrieder. Retrieved from https://idiyas.com/inventor/nikolaus-osterrieder-nlddr3cr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2014-2017

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9555101 - Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof (2017-01-31),

2. 8916371 - Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof (2014-12-23),

3. 8637046 - Bovine herpes virus-1 compositions, vaccines and methods (2014-01-28),

Title: Nikolaus Osterrieder: Innovator in Equine Health

Introduction

Nikolaus Osterrieder is a prominent inventor based in Potsdam, Germany. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for equine herpesvirus. With a total of 3 patents to his name, Osterrieder's work has had a lasting impact on animal health.

Latest Patents

Osterrieder's latest patents include the "Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof." This invention provides compositions or vaccines that contain a recombinant EHV-1, which elicits an immune response in animals against equine herpesvirus. The patent outlines methods of vaccination against equine herpesvirus and kits for use with such methods and compositions.

Career Highlights

Throughout his career, Nikolaus Osterrieder has worked with notable organizations such as Merial Limited and Cornell University. His expertise in virology and immunology has positioned him as a leader in the development of innovative solutions for equine health.

Collaborations

Osterrieder has collaborated with esteemed colleagues in his field, including Jean Christophe Audonnet and Jules Maarten Minke. These partnerships have further advanced research and development in veterinary vaccines.

Conclusion

Nikolaus Osterrieder's contributions to equine health through his innovative patents and collaborations highlight his dedication to improving animal welfare. His work continues to influence the field of veterinary medicine and vaccine development.

Profile summary based on public USPTO records.